UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 103 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$35,000
+16.7%
22,2990.0%0.00%
Q2 2016$30,000
-74.6%
22,2990.0%0.00%
Q1 2016$118,000
-34.8%
22,299
-3.5%
0.00%
Q4 2015$181,000
-14.6%
23,119
-8.0%
0.00%
Q3 2015$212,000
-22.9%
25,1190.0%0.00%
Q2 2015$275,000
-14.9%
25,119
+8.7%
0.00%
Q1 2015$323,000
-13.6%
23,119
+4.5%
0.00%
Q4 2014$374,000
+41.1%
22,119
+12.2%
0.00%
Q3 2014$265,000
+5.6%
19,7190.0%0.00%
Q2 2014$251,000
-92.8%
19,719
-93.3%
0.00%
-100.0%
Q1 2014$3,481,000
-25.0%
292,725
-12.9%
0.00%
-20.0%
Q4 2013$4,643,000
-18.8%
336,219
+2.6%
0.01%
-28.6%
Q3 2013$5,717,000
+48.6%
327,619
+38.4%
0.01%
+40.0%
Q2 2013$3,847,000236,7190.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
OLD POINT TRUST & FINANCIAL SERVICES N A 500$00.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders